Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,781,233B 4,107B 3,833B 3,518B 6,585B 447,663B 6,748B 45,456B 17,777B 221,522B 17,547B 17,166B 765,797B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 7,018,133B 4,250B 3,967B 3,641B 6,816B 463,302B 6,984B 47,044B 18,398B 229,261B 18,160B 17,766B 792,550B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.4%
Yield 2019 *
-
Yield 2020 -
1 day-3.51%
1 week+0.65%
Current month-5.87%
1 month-2.16%
3 months-33.51%
6 months-47.97%
Current year-33.62%
1 week 37,600
Extreme 37600
41,600
1 month 37,600
Extreme 37600
43,300
Current year 37,600
Extreme 37600
78,300
1 year 37,600
Extreme 37600
78,300
3 years 37,600
Extreme 37600
124,463.12
5 years 37,600
Extreme 37600
146,932.97
10 years 13,660.97
Extreme 13660.9749
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 68 28/03/2025
Chairman 42 26/03/2024
Director/Board Member 61 26/03/2024
Date Insider Type Main position Quantity % Market Cap.
5/7/25 A Fiscal year 4,500 0.0103%
5/7/25 A Others 127 0.0003%
5/7/25 A Others 24 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-3.51%+0.65%-25.77%-51.08% 1.21B
+0.67%+1.43%+16.90%+74.77% 49.64B
+1.05%+3.84%+64.12%+113.57% 36.54B
+2.06%+2.92%-6.22%+25.17% 12.22B
+2.14%-1.78%+14.55%+75.28% 11.48B
+1.05%+1.16%+31.33%+131.86% 9.04B
+3.08%+3.94%+50.54%-4.41% 6.94B
+0.17%-0.34%+12.61%+31.76% 6.74B
+3.53%+0.87%+5.47%+183.15% 6.45B
+0.61%-6.24%-32.70%-1.66% 5.42B
Average +1.08%-0.81%+13.08%+57.84% 14.57B
Weighted average by Cap. +1.20%+0.44%+26.22%+79.08%

Financials

2019 2020
Net sales 174B 251,757B 152B 142B 131B 244B 16,620B 251B 1,688B 660B 8,224B 651B 637B 28,431B 234B 338,894B 205B 192B 176B 329B 22,372B 337B 2,272B 888B 11,071B 877B 858B 38,271B
Net income 8.6B 12,481B 7.56B 7.06B 6.48B 12.12B 824B 12.42B 83.66B 32.72B 408B 32.3B 31.6B 1,409B 20.94B 30,382B 18.4B 17.17B 15.76B 29.51B 2,006B 30.23B 204B 79.65B 992B 78.62B 76.91B 3,431B
Net Debt 149B 215,542B 131B 122B 112B 209B 14,229B 214B 1,445B 565B 7,041B 558B 546B 24,341B 163B 236,901B 143B 134B 123B 230B 15,639B 236B 1,588B 621B 7,739B 613B 600B 26,753B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
29/07/26 38,500.00 -3.51% 163,461
28/07/26 ₩39,900.00 -2.33% 77,453
27/07/26 ₩40,850.00 +1.11% 55,909
24/07/26 ₩40,400.00 +3.46% 113,075
23/07/26 ₩39,050.00 +2.76% 106,060
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock